uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Net Cash Flow (2016 - 2026)

uniQure (QURE) posted quarterly Net Cash Flow of $273.8 million for Q2 2026, up 724.15% year-over-year from $33.2 million in Q2 2025, and up 349.83% quarter-over-quarter from $60.9 million in Q1 2026.

Analysis

uniQure (QURE) Net Cash Flow (2016 - 2026) Analysis & Trends

uniQure's Net Cash Flow history runs 11 years deep, the most recent figure standing at $273.8 million for Q2 2026.

  • In Q2 2026, Net Cash Flow rose 724.15% year-over-year to $273.8 million; the TTM figure through Jun 2026 stood at $160.6 million (up 522.15% YoY), while the FY2025 annual figure was -$84.2 million, down 6.23% from the prior year.
  • Net Cash Flow for Q2 2026 stood at $273.8 million, up from $60.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $359.0 million in Q2 2023, with the low at -$516.5 million in Q4 2025.
  • The 5-year median for Net Cash Flow is -$8.4 million (2022), against an average of -$8.0 million.
  • The sharpest annual moves came in 2022 and 2023: Net Cash Flow plunged 971.33% in 2022, then jumped 1877.17% in 2023.
  • uniQure's Net Cash Flow stood at -$222.3 million in 2022, then jumped by 104.53% to $10.1 million in 2023, then slumped by 954.13% to -$86.0 million in 2024, then slumped by 500.67% to -$516.5 million in 2025, then jumped by 153.01% to $273.8 million in 2026.
  • Business Quant data shows QURE's Net Cash Flow at $273.8 million in Q2 2026, $60.9 million in Q1 2026, and -$516.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 273.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 273.80 Mn
Mar 31, 2026 60.87 Mn
Dec 31, 2025 -516.49 Mn
Sep 30, 2025 342.42 Mn
Jun 30, 2025 33.22 Mn
Mar 31, 2025 56.67 Mn
Dec 31, 2024 -85.99 Mn
Sep 30, 2024 -41.95 Mn
Jun 30, 2024 45.23 Mn
Mar 31, 2024 3.41 Mn
Dec 31, 2023 10.07 Mn
Sep 30, 2023 -282.75 Mn
Jun 30, 2023 358.97 Mn
Mar 31, 2023 -75.18 Mn
Dec 31, 2022 -222.29 Mn
Sep 30, 2022 -53.75 Mn
Jun 30, 2022 -20.20 Mn
Mar 31, 2022 -30.11 Mn
Dec 31, 2021 -20.75 Mn
Sep 30, 2021 -97.96 Mn